US Patent Issued to Merck Sharp & Dohme on Oct. 6 for "Diaminopyrimidine carboxamide inhibitors of HPK1" (Massachusetts, New Jersey Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,163, issued on Oct. 6, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).

"Diaminopyrimidine carboxamide inhibitors of HPK1" was invented by Abdelghani Achab (Melrose, Mass.), David A. Candito (Wrentham, Mass.), Anthony Donofrio (Cambridge, Mass.), Xavier Fradera (Boston), Shuhei Kawamura (Cambridge, Mass.), Samuel M. Levi (Medford, Mass.), Bing Li (Towaco, N.J.), Anilkumar G. Nair (Morganville, N.J.), Alexander Pasternak (Jamaica Plain, Mass.), Brandon A. Vara (Boston) and Elsie C. Yu (Brighton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds of the formula I: or the pharmaceutically acceptable salts thereof, are inhibitors of ha...